Barisone G - Search Results

1

Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia.

Tuscano J, Poh C, Rosenberg A, Jonas B, Abedi M, Barisone G, Schwab E, Lundeberg K, Kaesberg P. Tuscano J, et al. Among authors: barisone g. J Hematol. 2020 Sep;9(3):79-83. doi: 10.14740/jh721. Epub 2020 Aug 14. J Hematol. 2020. PMID: 32855756 Free PMC article.

2

A purified, fermented, extract of Triticum aestivum has lymphomacidal activity mediated via natural killer cell activation.

Barisone GA, O'Donnell RT, Ma Y, Abuhay MW, Lundeberg K, Gowda S, Tuscano JM. Barisone GA, et al. PLoS One. 2018 Jan 5;13(1):e0190860. doi: 10.1371/journal.pone.0190860. eCollection 2018. PLoS One. 2018. PMID: 29304125 Free PMC article.

3

Efficacy of Combined Histone Deacetylase and Checkpoint Kinase Inhibition in a Preclinical Model of Human Burkitt Lymphoma.

Kong Y, Barisone GA, Sidhu RS, O'Donnell RT, Tuscano JM. Kong Y, et al. Among authors: barisone ga. Mol Med. 2015 Nov;21(1):824-832. doi: 10.2119/molmed.2015.00032. Epub 2015 Aug 24. Mol Med. 2015. PMID: 26322845 Free PMC article.

4

Histone deacetylase inhibition enhances the lymphomacidal activity of the anti-CD22 monoclonal antibody HB22.7.

Kong Y, Barisone GA, Abuhay M, O'Donnell RT, Buksh Z, Yousefian F, Tuscano JM. Kong Y, et al. Among authors: barisone ga. Leuk Res. 2014 Nov;38(11):1320-6. doi: 10.1016/j.leukres.2014.08.014. Epub 2014 Aug 30. Leuk Res. 2014. PMID: 25241275

5

The HB22.7-vcMMAE antibody-drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity.

Abuhay M, Kato J, Tuscano E, Barisone GA, Sidhu RS, O'Donnell RT, Tuscano JM. Abuhay M, et al. Among authors: barisone ga. Cancer Immunol Immunother. 2016 Oct;65(10):1169-75. doi: 10.1007/s00262-016-1873-y. Epub 2016 Aug 9. Cancer Immunol Immunother. 2016. PMID: 27506529 Free PMC article.

6

Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.

Satake N, Duong C, Chen C, Barisone GA, Diaz E, Tuscano J, Rocke DM, Nolta J, Nitin N. Satake N, et al. Among authors: barisone ga. Br J Haematol. 2014 Nov;167(4):487-99. doi: 10.1111/bjh.13066. Epub 2014 Sep 8. Br J Haematol. 2014. PMID: 25196579 Free PMC article.

7

KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth.

Shimoda M, Lyu Y, Wang KH, Kumar A, Miura H, Meckler JF, Davis RR, Chantarasrivong C, Izumiya C, Tepper CG, Nakajima KI, Tuscano J, Barisone G, Izumiya Y. Shimoda M, et al. Among authors: barisone g. Commun Biol. 2021 Dec 2;4(1):1330. doi: 10.1038/s42003-021-02853-0. Commun Biol. 2021. PMID: 34857874 Free PMC article.

8

Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.

Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N. Duong C, et al. Among authors: barisone g. Pediatr Res. 2017 Sep;82(3):527-535. doi: 10.1038/pr.2017.74. Epub 2017 May 31. Pediatr Res. 2017. PMID: 28419087 Free PMC article.

9

DNA microarrays: sample quality control, array hybridization and scanning.

Diaz E, Barisone GA. Diaz E, et al. J Vis Exp. 2011 Mar 15;(49):2546. doi: 10.3791/2546. J Vis Exp. 2011. PMID: 21445042 Free PMC article.

10

Focus formation: a cell-based assay to determine the oncogenic potential of a gene.

Alvarez A, Barisone GA, Diaz E. Alvarez A, et al. Among authors: barisone ga. J Vis Exp. 2014 Dec 31;(94):51742. doi: 10.3791/51742. J Vis Exp. 2014. PMID: 25590282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page